Author:
Mullins Tanya L. Kowalczyk,Widdice Lea E.,Rosenthal Susan L.,Zimet Gregory D.,Kahn Jessica A.
Funder
NIAID
Cincinnati Children's Research Foundation Procter Scholar Award
NICHD
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference39 articles.
1. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases;Garland;N Engl J Med,2007
2. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions;Group FIS;N Engl J Med,2007
3. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials;Joura;Lancet,2007
4. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia;Palefsky;N Engl J Med,2011
5. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP);Centers for Disease C, Prevention;MMWR,2010
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献